AbCellera Biologics Inc. SEC filings ABCL
AbCellera Biologics Inc. has 322 filings in SEC EDGAR's recent list, going back to Apr 6, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Other events
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Auditor change
|
Nov 28, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 30, 2025 |
| 8-K |
Current report
Other events
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Other events
|
May 13, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 20, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 24, 2023 | May 24, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2022 | Jul 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 7, 2021 | Dec 7, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2021 | Dec 2, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Other events
|
Sep 23, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Other events
|
Sep 15, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Jul 13, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 15, 2021 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
May 17, 2021 | May 13, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Other events
|
Apr 1, 2021 | Apr 1, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Other events
|
Mar 2, 2021 | Feb 26, 2021 |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABCL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1703057
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.